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Edited by Miguel De la RosaAbstract Scrambled isomers (X-isomers) are fully oxidized,
non-native isomers of disulﬁde proteins. They have been shown
to represent important intermediates along the pathway of oxi-
dative folding of numerous disulﬁde proteins. A simple method
to assess whether X-isomers present as folding intermediate is
to conduct oxidative folding of fully reduced protein in the alka-
line buﬀer alone without any supplementing thiol catalyst or
redox agent. Cardiotoxin-III (CTX-III) contains 60 amino acids
and four disulﬁde bonds. The mechanism of oxidative folding of
CTX-III has been systematically characterized here by analysis
of the acid trapped folding intermediates. Folding of CTX-III
was shown to proceed sequentially through 1-disulﬁde, 2-disul-
ﬁde, 3-disulﬁde and 4-disulﬁde (scrambled) isomers as folding
intermediates to reach the native structure. When folding of
CTX-III was performed in the buﬀer alone, more than 97% of
the protein was trapped as 4-disulﬁde X-isomers, unable to con-
vert to the native structure due to the absence of thiol catalyst. In
the presence of thiol catalyst (GSH) or redox agents (GSH/
GSSG), the recovery of native CTX-III was 80–85%. These
results demonstrate that X-isomers play an essential and
predominant role in the oxidative folding of CTX-III.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Folding of disulﬁde proteins can be investigated by track-
ing the path of disulﬁde oxidation of their fully reduced
and denatured isomers en route to the native disulﬁde struc-
tures [1]. This so-called disulﬁde folding pathway is generally
deﬁned by: (a) The heterogeneity of disulﬁde isomers appear-
ing as folding intermediates; (b) The presence/absence of pre-
dominant intermediates adopting native disulﬁde bonds; (c)
The presence/absence of kinetic traps; and (d) The presence/Abbreviations: CTX-III, cardiotoxin III; BPTI, bovine pancreatic
trypsin inhibitor; PCI, potato carboxypeptidase inhibitor; TAP, tick
anticoagulant peptide; DTT, dithiothreitol; GdmCl, guanidine hydro-
chloride; HPLC, high-performance liquid chromatography
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(These isomers are also termed as scrambled isomers and
abbreviated as X-isomers). Two of the best characterized
models are bovine pancreatic trypsin inhibitor (BPTI) [2–4]
and bovine ribonuclease A (RNase A) [5,6]. In the case of
3-disulﬁde BPTI, the folding pathway is characterized by a
limited number of 1- and 2-disulﬁde intermediates that adopt
native disulﬁde bonds and native-like structures. Out of 74
possible disulﬁde isomers, only ﬁve to six 1- and 2-disulﬁde
intermediates were shown to populate along the folding path-
way of BPTI and all of them were shown to adopt native
disulﬁde bonds [4,7]. X-isomers of BPTI were not found in
the folding pathway of BPTI. In the case of 4-disulﬁde
RNase A, the folding intermediates are more heterogeneous
and X-isomers of RNase A were shown to be present along
the pathway [5,6]. Subsequent studies of other 3- and 4-disul-
ﬁde proteins further revealed a large diversity of disulﬁde
folding pathway [8–24].
Despite the absence of 3-disulﬁde X-isomer in the well-doc-
umented pathway of BPTI folding, it is now abundantly clear
that X-isomers are essential intermediates of oxidative folding
for numerous disulﬁde proteins [8–15,17]. A simple method
to evaluate whether X-isomers present as folding intermediate
is to conduct oxidative folding of fully reduced protein in the
alkaline buﬀer without supplementing any thiol catalyst or re-
dox agent. If X-isomers represent signiﬁcant intermediates in
the folding process, a fraction of them will most likely be
trapped along the folding pathway. The end product of fold-
ing will always comprise a mixture of native (N) and fully
oxidized X-isomers. However, the extent of participation of
X-isomers diﬀers and the end N/X ratio may vary from pro-
tein to protein.
In this communication, we have conducted oxidative folding
of cardiotoxin III (CTX-III) in order to further understand the
diversity of disulﬁde folding pathway. CTX-III is isolated from
the Taiwan Cobra (Naja naja atra) [25]. It is a highly basic
(pI > 10), small molecular weight (6.8 kDa), all b-sheet pro-
teins crosslinked by four disulﬁde bridges [26,27]. Solution
structure of CTX-III revealed that it is a ‘‘three ﬁnger’’ shaped
protein with three loops emerging from a globular head [28].
The head region of the molecule is fortiﬁed by the presence
of four disulﬁde bonds formed between cysteine residues lo-
cated at position 3–21, 14–38, 42–53 and 54–59 [28]. The re-
sults of our studies reveal that X-isomers play a predominant
role in the pathway of oxidative folding of CTX-III that has
not yet been observed in other disulﬁde proteins.blished by Elsevier B.V. All rights reserved.
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2.1. Material
CTX-III was isolated from the Taiwan Cobra (Naja naja
atra) [25]. The protein is more than 95% pure as judged by
high-performance liquid chromatography (HPLC) and N-ter-
minal sequence analysis. Dithiothreitol (DTT), guanidine
hydrochloride (GdmCl), reduced glutathione (GSH), oxidized
glutathione (GSSG), and b-mercaptoethanol were products of
Sigma with purity of greater than 99%.
2.2. Oxidative folding of the fully reduced CTX-III
The native CTX-III (2 mg/ml) was ﬁrst reduced and dena-
tured in the Tris–HCl buﬀer (0.1 M, pH 8.4) containing 5 M
of GdmCl and 30 mM of DTT. Reduction and denaturation
was carried out at 22 C for 90 min. To initiate the folding,
the sample was passed through a PD-10 column (Pharmacia)
equilibrated in the 0.1 M Tris–HCl buﬀer (pH 8.4). Reduced
and denatured CTX-III was recovered in a volume of 1.1 ml,
which was immediately diluted with the same Tris–HCl buﬀer
to a ﬁnal protein concentration of 0.5 mg/ml and with selected
concentrations of redox agents. Folding intermediates of CTX-
III were trapped in a time-course manner by mixing aliquots of
the sample with an equal volume of 4% triﬂuoroacetic acid in
water. Trapped folding intermediates were analyzed by HPLC
or stored at 20 C.
2.3. Determination of the number of disulﬁde bonds of folding
intermediates
To quantify the distributions of disulﬁde species (the fully re-
duced, 1-, 2-, 3-, and 4-disulﬁde isomers) of time-course folding
samples, the folding intermediates of CTX-III were directlyFig. 1. Oxidative folding of reduced CTX-III in the absence and presence
conditions. (A) Tris–HCl buﬀer (0.1 M, pH 8.4) alone. (B) Tris–HCl buﬀer (0
of folding were withdraw at diﬀerent time points, quenched with an equal vo
HPLC using the following conditions. Solvent A was water containing 0.1%
containing 0.1% triﬂuoroacetic acid. The gradient was 20–56% solvent B l
4.6 mm, 10 lm. Column temperature was 23 C. The composition of interm
possible isomers. ‘‘R’’ and ‘‘N’’ indicate the elution positions of the fully red
early on HPLC throughout all chromatograms is a contaminant that existsand collectively derivatized with vinylpyridine (0.13 M) for
35 min at 23 C in dark. Derivatized samples were acidiﬁed,
desalted by gelﬁltration and analyzed by MALDI mass spec-
trometry. The fully reduced CTX-III and fully oxidized
CTX-III exhibit molecular mass of 7587 and 6739, respec-
tively. Formation of each additional disulﬁde bond reduces
the molecular mass by 212.
2.4. Mass spectrometry
Molecular mass of folding intermediates of CTX-III, follow-
ing modiﬁcation with vinylpyridine were determined by MAL-
DI-TOF mass spectrometer (Perkin–Elmer Voyager-DE STR)
using 2,5-dihydroxybenzoic acid as matrix. Molecular mass of
analyzed peptides were calibrated by the following standards.
Bradykinin fragment (residues 1–7) (MH+ 757.3997); Synthetic
peptide P14R (MH+ 1533.8582); ACTH fragment (residues
18–39) (MH+ 2465.1989); and Insulin oxidized B-chain
(MH+ 3494.6513).3. Results and discussion
3.1. Oxidative folding of reduced CTX-III
Oxidative folding of the fully reduced CTX-III was carried
out at alkaline pH in the absence and presence of thiol catalyst
and redox agent. Folding intermediates were trapped by acid-
iﬁcation and analyzed by HPLC (Fig. 1). The results show that
folding intermediates of CTX-III consist of heterogeneous iso-
mers exhibited by a broad peak comprising overlapped frac-
tions. Quantiﬁcation of any predominant fraction is
unfeasible due to the complexity of folding intermediates.
Molecular mass analysis of collective intermediates withdrawof thiol catalyst. Folding was performed at 23 C using the following
.1 M, pH 8.4) containing b-mercaptoethanol (0.25 mM). Intermediates
lume of 4% aqueous triﬂuoroacetic acid and analyzed by reverse-phase
triﬂuoroacetic acid. Solvent B was acetonitrile/water (9:1, by volume)
inear in 30 min. Column was Vydac C-18 for peptides and proteins,
ediates is expected to be heterogeneous due to the large number of
uced and the native CTX-III, respectively. One minor peak appearing
in the starting material of folding.
Fig. 3. Recovery of the native CTX-III using diﬀerent conditions of
oxidative folding. Folding of reduced CTX-III was carried out at 23 C
in the Tris–HCl buﬀer (0.1 M, pH 8.4) containing no thiol catalyst or
redox agent (n); b-mercaptoethanol (0.25 mM) (h); GSH (0.25 mM)
(s); GSH (1 mM) (m); and GSH/GSSG (1 mM/0.5 mM) (d).
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demonstrates that folding of CTX-III undergoes sequentially
1-, 2-, 3-disulﬁde isomers to reach the fully oxidized 4-disulﬁde
CTX-III (Fig. 2).
However, the yield of 4-disulﬁde CTX-III does not coincide
with that of native CTX-III. When folding was performed in
the buﬀer alone (Fig. 1A), the end-product of folding contains
less than 3% of the N-CTX-III. The remaining 97% was stuck
as X-CTX-III, unable to convert to the native structure due to
the absence of free thiol. In the presence of thiol catalyst
(0.25 mM b-mercaptoethanol) (Fig. 1B), about 40% of the 4-
disulﬁde isomers was recovered as the N-CTX-III after 24 h
of folding. In comparing the results of folding experiments per-
formed in the absence and presence of b-mercaptoethanol
(Figs. 1 and 2A and B), it becomes clear that the only signiﬁ-
cant diﬀerence is the yield of N-CTX-III among recovered
4-disulﬁde isomers. The recovery of N-CTX-III can be further
improved by applying more eﬀective thiol catalysts (0.25 mM
or 1 mM GSH) or redox agents (Fig. 3). When oxidative fold-
ing of CTX-III was carried out in the same Tris–HCl buﬀer
containing GSH/GSSG (1 mM/0.5 mM), which promotes both
disulﬁde oxidation and disulﬁde shuﬄing, about 86% recovery
of the native structure was achieved (Fig. 3).
3.2. The pathway of oxidative folding of CTX-III
The results obtained from the systematic folding experi-
ments described above indicate that the basic pathway ofFig. 2. Composition of disulﬁde species identiﬁed along the folding
pathway of CTX-III. Folding of CTX-III was carried out at 23 C in
the following buﬀer. (A) Tris–HCl buﬀer (0.1 M, pH 8.4) alone. (B)
Tris–HCl buﬀer (0.1 M, pH 8.4) containing b-mercaptoethanol
(0.25 mM). The folding intermediates were trapped by reaction with
vinylpyridine and analyzed by MALDI-MS. The folding intermediates
of CTX-III comprise various concentrations of isomers adopting 0- to
4-disulﬁde pairings. As a result of the reaction with vinylpyridine, these
ﬁve populations of disulﬁde isomers can be distinguished by their
relative molecular mass and identiﬁed by MALDI mass spectrometry.
Each additional pair of vinylpyridine modiﬁcation increases the
molecular mass by 212 Da.in vitro oxidative folding of CTX-III is indistinguishable from
that of several disulﬁde proteins, including hirudin [8,9], tick
anticoagulant peptide (TAP) [10], potato carboxypeptidase
inhibitor (PCI) [12], leech carboxypeptidase inhibitor (LCI)
[13,14], and Amaranthus a-amylase inhibitor (AAI) [17]. Fold-
ing pathways of these proteins all share the following charac-
teristics: (a) a high degree of heterogeneity of folding
intermediates; (b) the absence of predominant intermediates
adopting exclusively native disulﬁde bonds; and (c) the pres-
ence of fully oxidized scrambled isomers as essential folding
intermediates.
A ﬂow chart of folding pathway of CTX-III is depicted in
Fig. 4. This diagram is used to explain the accumulation and
trapping of X-isomers when the folding was carried out in
the buﬀer alone (Fig. 1A). Under this simple folding condition,
disulﬁde oxidation is promoted by air oxygen. The slow pro-
cess of disulﬁde formation leads the sequential ﬂow of reduced
CTX-III through 1-, 2- and 3-disulﬁde intermediates to form 4-
disulﬁde X-CTX-III. Conversion of X-CTX-III to form the N-
CTX-III represents the ﬁnal stage of folding and requires free
thiol as catalyst. During the early stage of folding, this process
is catalyzed by free cysteines of partially oxidized intermedi-
ates, and about 3% of the CTX-III is able to attain the native
structure. As the folding advances, free cysteines deplete com-
pletely, the protein therefore becomes trapped as X-CTX-III,
unable to move further. The inclusion of GSSG/GSH in the
folding buﬀer accelerates the kinetics of both disulﬁde oxida-
tion and disulﬁde shuﬄing, and consequently generates a high-
er recovery of native CTX-III. However, the folding pathway
remains unaﬀected regardless of the folding conditions ap-
plied. This phenomenon has been described in detail in the case
of hirudin folding [9].
Indeed, the pathway of oxidative folding of CTX-III may
have been predictable based on the pathway of its reductive
unfolding [29]. We have previously shown that for most disul-
ﬁde proteins, there is striking correlation between the path-
ways of their reductive unfolding and oxidative folding [30].
Those with their disulﬁde bonds reduced (by DTT) in an all-
or-none manner were shown to exhibit both a high degree of













Free (SH) of partially oxidized
intermediates catalyze X    N
Native proteinFully oxidized
intermediates
k R X k X N
Fig. 4. A ﬂow chart of the disulﬁde folding pathway of CTX-III. Folding of reduced CTX-III undergoes 1-, 2- and 3-disulﬁde isomers to reach 4-
disulﬁde X-isomers as essential intermediates. Conversion of X-CTX-III to form N-CTX-III represents the ﬁnal stage of folding and requires free
thiol as catalyst. When folding was performed in the buﬀer alone, partially oxidized 1-, 2- and 3-disulﬁde intermediates may function as transient
thiol catalyst to promote the X)N conversion. The extent of accumulation of X-CTX-III during the folding is dictated by two major kinetic
parameters (kR)X and kX)N) which in turn are dependent upon the redox conditions.
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(e.g. hirudin, TAP and PCI) [8–12]. Those with their disulﬁde
bonds reduced in a sequential fashion during the reductive
unfolding display in their folding pathway limited species of
intermediates adopting mainly native disulﬁde bonds (e.g.
BPTI and EGF) [2,4,11]. Reductive unfolding of the four
disulﬁde bonds of N-CTX-III was shown to occur in a collec-
tive and simultaneous manner [29]. This is consistent with its
hirudin-like folding pathway [8,9].3.3. The extent of accumulation of fully oxidized X-isomers
along the folding pathway of CTX-III is unprecedented
Despite the similarity of folding pathways between CTX-III
and numerous hirudin-like disulﬁde proteins, the extent of
accumulation of X-CTX-III as folding intermediates is unique
and remarkable. When folding of CTX-III was performed in
the buﬀer alone, more than 97% of the protein was shown to
be trapped as X-CTX-III (Fig. 1A). This amount has not been
found so far in other proteins. Under identical folding condi-
tions as those described in Fig. 1A, the level of X-isomers
trapped as folding intermediates typically ranges from 35%
to 65% of the total protein, with an average deviation of
±10% [8–13]. None of the X-isomers of other proteins play
such a predominant role similar to that of X-CTX-III.
The extent of accumulation of X-isomers is dependent upon
two major kinetic parameters, the rate of their formation
(kR)N) and the rate of their conversion to the native protein
(kX)N) (Fig. 4). A greater kR)X combined with a lower kX)N
would result in a higher concentration of trapped X-isomers
during the folding. In the case of CTX-III, the high concentra-
tion of X-CTX-III accumulation can be explained at least
partly by the slow process of disulﬁde shuﬄing of X-CTX-
III (lower kX)N). For all other proteins that have been inves-
tigated in our laboratory [8–12], including the 4-disulﬁdes LCI
[13,14], a near quantitative recovery of native proteins can be
accomplished by simply including a thiol catalyst in the folding
buﬀer, a folding condition identical to that given in Fig. 1B.
This is not the case for CTX-III as shown in Fig. 1B and
2B. Results obtained from experiments using puriﬁed X-iso-
mers as starting materials also indicate that under identical
conditions, kX)N for X-CTX-III [29] is at least 8-fold lower
than that of X-Hirudin [9].
The mechanism of oxidative folding of CTX-III is even more
remarkable, if one compare it with another synthetic neuro-toxin a62, which is also a ‘‘three ﬁngers’’, all b-sheet, 4-disul-
ﬁde protein structurally homologous to CTX-III. Oxidative
folding of neurotoxin a62 undergoes two native-like 3-disulﬁde
intermediates and displays a BPTI-like folding pathway [31].
These diﬀerences are reminiscent of that observed between
the folding pathways of BPTI and TAP. Although TAP is
structurally homologous to BPTI, the pathway of oxidative
folding of TAP bears a strong resemblance to that of hirudin
[10], with high heterogeneity of folding intermediates and the
accumulation of scrambled isomers along the folding pathway.
3.4. Unique properties of the lysine residues of CTX-III
One of the unique features of CTX-III folding is that the na-
tive CTX-III exhibits a longer retention time than any other
folding intermediates on reversed phased HPLC. This phe-
nomenon is unique because, for most proteins, the native
structure is typically more hydrophilic than partially folded
intermediates and usually eluted earlier on the HPLC with
mechanism of separation based primarily on hydrophobic
interaction. The abnormal behavior of CTX-III is likely attrib-
uted to the role of its lysyl residues. Basic amino acids, like ly-
sine and arginine, despite their hydrophilicity, are known to
exhibit prolonged retention time due to their interaction with
silica based support of reversed phased chromatography.
CTX-III is a basic protein with high content of basic amino
acids. There are 9 Lys and 2 Arg out of 60 amino acid residues
of CTX-III. In the native structure of CTX-III, most lysines
are found to locate on the surface of the protein [28] and their
interaction with the silica based support may account for this
unusual property of CTX-III. The unique property of these ly-
syl residues was further demonstrated by their unusual high
reactivity toward cyanate contaminant that exists in the urea
solution [29]. CTX-III is not alone in displaying this property.
All scrambled isomers of denatured PCI (X-PCI) also exhibit
shorter retention time and elute earlier than N-PCI on revered
phase HPLC [12].
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